The management of advanced thyroid cancer

PC Wilson, BM Millar, JD Brierley - Clinical Oncology, 2004 - Elsevier
Although the prognosis of the majority of patients with thyroid cancer is excellent there are
some patients with advanced thyroid cancer in whom the prognosis is poor. Such patients …

Thyroid cancer causing obstruction of the great veins in the neck

SL Hyer, P Dandekar, K Newbold, M Haq… - World Journal of …, 2008 - Springer
Background and aims To report our experience and review the literature of thyroid cancer
obstructing the great veins in the neck, highlighting clinical aspects and response to …

Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells

ML Schipper, A Weber, M Béhé, R Göke, W Joba… - Cancer research, 2003 - AACR
This study evaluates the possibility of treating Bon1 and QGP pancreatic neuroendocrine
tumor cells with radioactive iodide (131I) after stable transfection with the thyroid sodium …

Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo

ML Schipper, CGU Riese, S Seitz, A Weber… - European journal of …, 2007 - Springer
Purpose There is growing interest in the human sodium/iodide symporter (NIS) gene both as
a molecular imaging reporter gene and as a therapeutic gene. Here, we show the feasibility …

Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation

M Azrif, NJ Slevin, AJ Sykes, R Swindell… - Radiotherapy and …, 2008 - Elsevier
INTRODUCTION: Post-operative residual disease in differentiated thyroid cancer is an
indication for external beam radiotherapy (EBRT) especially if there is poor radioiodine …

The role of external beam radiation therapy in well-differentiated thyroid cancer

SN Hamilton, E Tran, E Berthelet… - Expert Review of …, 2017 - Taylor & Francis
Introduction: This review article explores the use of external beam radiotherapy (EBRT) in
well differentiated thyroid cancer. Areas covered: The published literature on EBRT for …

Empirically treating high serum thyroglobulin levels

EL Mazzaferri - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
For few tumors are there such accurate and specific tools for diagnosis and treatment as
those routinely used in the management of differentiated thyroid carcinoma (DTC). Highly …

The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies

RBT Verkooijen, FA Verburg… - European journal of …, 2008 - academic.oup.com
Introduction The aim of the study was to compare the success rate of an uptake-related
ablation protocol in which the dose depends on an I-131 24-h neck uptake measurement …

[HTML][HTML] The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea

YS Kim, JH Choi, KS Kim, GC Lim, JH Kim… - Radiation Oncology …, 2017 - ncbi.nlm.nih.gov
Purpose To evaluate the effect of adjuvant external beam radiation therapy (EBRT) on local
failure-free survival rate (LFFS) for papillary thyroid cancer (PTC) invading the trachea …

Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription

M Pashnehsaz, A Takavar, S Izadyar… - World journal of …, 2016 - thieme-connect.com
Iodine-131 (I-131) therapy is one of the conventional approaches in the treatment of patients
with differentiated thyroid carcinoma (DTC). The radioiodine agents also accumulate in the …